Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Curr Protein Pept Sci ; 19(2): 145-154, 2018.
Artigo em Inglês | MEDLINE | ID: mdl-28901250

RESUMO

X-box binding protein 1 (XBP-1) is a key regulator of the unfolded protein response (UPR), which is activated in response to endoplasmic reticulum (ER) stress. Cells contain two protein isoforms of XBP-1, the active isoform (XBP-1S) and the inactive isoform (XBP-1U). Induction of UPR leads to the generation of XBP-1S while XBP-1U is dominant in ER stress-free cells. XBP-1S is a transcriptional activator and regulates the expression of a subset of UPR genes. Importantly, recent studies have demonstrated the essential role of XBP-1S in various human diseases, such as viral infections. Many viruses have evolved to manipulate UPR/XBP-1 of the infected cells to promote viral survival and replication. In this review, we will summarize the current findings on the involvement of XBP-1 in viral infection/ replication and discuss the potential anti-viral strategies by targeting XBP-1.


Assuntos
Antivirais/farmacologia , Viroses/tratamento farmacológico , Proteína 1 de Ligação a X-Box/metabolismo , Antivirais/uso terapêutico , Estresse do Retículo Endoplasmático , Humanos , Dobramento de Proteína , Fatores de Transcrição/metabolismo , Resposta a Proteínas não Dobradas , Viroses/metabolismo , Viroses/virologia , Replicação Viral
2.
Mol Biotechnol ; 59(8): 315-322, 2017 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-28664508

RESUMO

Role of epigenetic regulation in the control of gene expression is well established. The impact of several epigenetic mechanisms, such as DNA methylation and histone acetylation, on recombinant protein production in mammalian cells has been investigated recently. Here we investigate the correlation between the selected epigenetic markers and five trastuzumab biosimilar-producing Chinese hamster ovary (CHO) cell lines in which the expression of trastuzumab is driven by human cytomegalovirus (HCMV) major immediate-early (MIE) promoter. We chose the producing clones in which transcription was the determinative step for the production of recombinant trastuzumab. We found that the abundance of trimethylation of histone 3 at lysine 4 (H3K4Me3) on the enhancer of HCMV MIE promoter correlated well with the relative titers of recombinant trastuzumab among the clones. Such close correlation was not observed between the recombinant protein and other epigenetic markers examined in our study. Our results demonstrate that the HCMV MIE enhancer-bound H3K4Me3 epigenetic marker may be used as the epigenetic indicator to predict the relative production of recombinant proteins between the producing CHO cell lines.


Assuntos
Citomegalovirus/genética , Elementos Facilitadores Genéticos , Genes Precoces , Histonas/metabolismo , Lisina/metabolismo , Regiões Promotoras Genéticas , Proteínas Recombinantes/metabolismo , Trastuzumab/metabolismo , Animais , Células CHO , Cricetinae , Cricetulus , Metilação de DNA , Dosagem de Genes , Humanos , Metilação , RNA Mensageiro/genética , RNA Mensageiro/metabolismo , Trastuzumab/biossíntese , Trastuzumab/genética
3.
BMC Biotechnol ; 16(1): 71, 2016 Oct 18.
Artigo em Inglês | MEDLINE | ID: mdl-27756290

RESUMO

BACKGROUND: Methylated CpG dinucleotides in promoters are associated with the loss of gene expression in recombinant Chinese hamster ovary (CHO) cells during large-scale commercial manufacturing. We evaluated a promoter devoid of CpG dinucleotides, CpGfree, in parallel with a similar CpG containing promoter, CpGrich, for their ability to maintain the expression of recombinant enhanced green fluorescent protein (EGFP) after 8 weeks of culturing. RESULTS: While the promoters gave similar transient expression levels, CpGfree clones had significantly higher average stable expression possibly due to increased resistance to early silencing during integration into the chromosome. A greater proportion of cells in clones generated using the CpGfree promoter were still expressing detectable levels of EGFP after 8 weeks but the relative expression levels measured at week 8 to those measured at week 0 did not improve compared to clones generated using the CpGrich promoter. Chromatin immunoprecipitation assays indicated that the repression of the CpGfree promoter was likely linked to histone deacetylation and methylation. Use of histone deacetylase inhibitors also managed to recover some of the lost expression. CONCLUSION: Using a promoter without CpG dinucleotides could mitigate the early gene silencing but did not improve longer-term expression stability as silencing due to histone modifications could still take place. The results presented here would aid in promoter selection and design for improved protein production in CHO and other mammalian cells.


Assuntos
Ilhas de CpG/genética , Melhoramento Genético/métodos , Regiões Promotoras Genéticas/genética , Proteínas Recombinantes/genética , Proteínas Recombinantes/metabolismo , Animais , Células CHO , Cricetulus , Estabilidade de Medicamentos , Proteínas Recombinantes/isolamento & purificação
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...